K. Lieve

发表

Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation.

A. Wilde, N. Hofman, C. Bezzina, 2017, International journal of cardiology.

Inherited ion channel diseases: a brief review.

A. Wilde, K. Lieve, 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Prognostic value of post-procedural aPTT in patients with ST-elevation myocardial infarction treated with primary PCI

J. Tijssen, R. D. de Winter, G. Dangas, 2013, Thrombosis and Haemostasis.

Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance.

A. Wilde, D. Tester, M. Ackerman, 2019, Circulation. Genomic and precision medicine.

Cardiorenal axis and arrhythmias: Will renal sympathetic denervation provide additive value to the therapeutic arsenal?

R. D. de Winter, A. Wilde, K. Lieve, 2015, Heart rhythm.

The Role of Flecainide in the Management of Catecholaminergic Polymorphic Ventricular Tachycardia.

A. Wilde, K. Lieve, C. van der Werf, 2016, Arrhythmia & electrophysiology review.

An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia

J. Skinner, E. Behr, P. Schwartz, 2021, Circulation.

Linking the heart and the brain: Neurodevelopmental disorders in patients with catecholaminergic polymorphic ventricular tachycardia.

A. Wilde, W. Shimizu, M. Ackerman, 2019, Heart rhythm.

Inherited Arrhythmias: Brugada Syndrome and Early Repolarisation Syndrome

P. Postema, A. Wilde, K. Lieve, 2018 .

Results of genetic testing in 855 consecutive unrelated patients referred for long QT syndrome in a clinical laboratory.

Leah M. Williams, W. Chung, S. Bale, 2011, Genetic testing and molecular biomarkers.

Determination and Interpretation of the QT Interval: Comprehensive Analysis of a Large Cohort of Long QT Syndrome Patients and Controls

P. Postema, A. Wilde, N. Blom, 2018, Circulation.

Recurrent myocardial infarction after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

P. Damman, J. Tijssen, R. D. de Winter, 2014, The American journal of cardiology.

Common and rare susceptibility genetic variants predisposing to Brugada Syndrome in Thailand.

T. Meitinger, K. Nademanee, W. Wongcharoen, 2020, Heart Rhythm.

Catecholaminergic Polymorphic Ventricular Tachycardia.

A. Wilde, K. Lieve, C. van der Werf, 2016, Circulation journal : official journal of the Japanese Circulation Society.

Pregnancy in Catecholaminergic Polymorphic Ventricular Tachycardia.

A. Wilde, A. Krahn, Jason D. Roberts, 2019, JACC. Clinical electrophysiology.

Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.

Yolan J. Reckman, A. Wilde, P. Postema, 2017, JACC. Clinical electrophysiology.

Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review.

P. Schwartz, N. Hawkins, A. Krahn, 2018, Heart rhythm.

Cardiac ryanodine receptor calcium release deficiency syndrome

S. Priori, C. Napolitano, A. Wilde, 2021, Science Translational Medicine.

An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia

Rahul C. Deo, J. Healey, C. January, 2020, Circulation.

Catecholaminergic Polymorphic Ventricular

A. Leenhardt, I. Denjoy, A. Maltret, 2020, Clinical Cardiogenetics.

Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia

A. Wilde, M. Ackerman, N. Blom, 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

An Evaluation of Age at Symptom-Onset, Proband Status and Sex as Predictors of Disease Severity in Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia.

A. Wilde, A. Krahn, P. Kannankeril, 2021, Heart rhythm.

Heart Rate Recovery After Exercise Is Associated With Arrhythmic Events in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

J. Skinner, P. Schwartz, A. Wilde, 2020, Circulation. Arrhythmia and electrophysiology.

Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.

J. Skinner, E. Behr, P. Schwartz, 2019, European heart journal.

Beta-blockers in the treatment of catecholaminergic polymorphic ventricular tachycardia.

K. Lieve, C. van der Werf, 2016, Heart rhythm.

Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.

A. Wilde, A. Krahn, G. Padfield, 2016, Heart rhythm.

Double trouble, stick to the basics should be the rule!

A. Wilde, K. Lieve, 2014, Heart rhythm.

Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death Single-Center

Yolan J. Reckman, P. Postema, N. Lahrouchi, 2017 .

An International Multicenter Cohort Study on Implantable Cardioverter Defibrillators for the Treatment of Symptomatic Children with Catecholaminergic Polymorphic Ventricular Tachycardia.

S. Ohno, T. Robyns, S. Sanatani, 2024, Heart rhythm.

Catecholaminergic Polymorphic Ventricular Tachycardia.

K. Lieve, C. Werf, A. A. Wilde, 2017, Pediatric emergency care.